Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.1B | 10.1B | 9.6B | 9.9B |
Cost of revenue | 5.5B | 6.3B | 6.3B | 6.3B |
Gross profit | 2.7B | 3.9B | 3.3B | 3.6B |
Operating expense | ||||
Research & development | 123M | 253M | 192M | 189M |
Selling general and admin | 121M | 183M | 125M | 128M |
Other operating expenses | 185M | 587M | 244M | 257M |
Operating income | 2.2B | 2.8B | 2.7B | 3.0B |
Non operating interest income | ||||
Income | 56M | 20M | 43M | 3M |
Expense | 285M | 508M | 272M | 525M |
Other income expense | 154M | -3.1B | 218M | 350M |
Pretax income | 2.0B | -901M | 2.7B | 2.7B |
Tax provision | 647M | -29M | 336M | -34M |
Net income | 1.4B | -872M | 2.4B | 2.8B |
Basic EPS | 0.3 | — | 0.6 | 0.7 |
Diluted EPS | 0.3 | — | 0.6 | 0.7 |
Basic average shares | 752.5M | — | 752.6M | 753.5M |
Diluted average shares | 753.4M | — | 753.5M | 754.4M |
EBITDA | 2.9B | 3.6B | 3.0B | 3.8B |
Net income from continuing op. | 2.0B | -901M | 2.7B | 2.7B |
Minority interests | -2M | 178M | 21M | 0 |
Preferred stock dividends | — | — | — | — |